PAM16 (presequence translocase associated motor 16), also known as Magmas, is a mitochondrial protein essential for ATP-dependent protein translocation into the mitochondrial matrix. PAM16 functions as a J-like protein subunit that forms heterodimeric complexes with J-proteins DnaJC19 and DnaJC15 1, thereby regulating the activity of the TIM23 import motor 2. Multiple PAM16 variants (Magmas-1 and Magmas-2) are expressed in mammals, with differential recruitment to distinct translocase machineries and differential inhibitory activity toward J-proteins 1. PAM16 demonstrates evolutionary conservation between human and yeast orthologs, with structural and functional homology 3. Clinically, PAM16 dysfunction associates with spondylometaphyseal dysplasia: homozygous MAGMAS mutations cause severe skeletal dysplasia through impaired mitochondrial preprotein import and subsequent cell death, with PAM16 specifically expressed during early bone and cartilage development 4. Heart failure patients show significant PAM16 downregulation alongside other mitochondrial quality control genes, indicating defective mitochondrial function 5. Additionally, PAM16 is overexpressed in ACTH-secreting pituitary adenomas and protects cells from apoptosis 6. These findings establish PAM16 as critical for both mitochondrial protein homeostasis and cellular viability.